Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.25 CAD | +11.11% | +11.11% | +8.70% |
Mar. 29 | Manitex Capital Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 | CI |
Feb. 28 | Manitex Capital Inc. Reports Earnings Results for the Full Year Ended October 31, 2023 | CI |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Steven Saviuk
CEO | Chief Executive Officer | 65 | 86-09-30 |
Helen Saviuk
DFI | Director of Finance/CFO | 71 | 10-03-28 |
Guy-Paul Allard
LAW | General Counsel | 56 | 16-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Tinmouth
BRD | Director/Board Member | - | 04-04-27 |
Steven Saviuk
CEO | Chief Executive Officer | 65 | 86-09-30 |
Helen Saviuk
DFI | Director of Finance/CFO | 71 | 10-03-28 |
Marc Bélair
BRD | Director/Board Member | - | 20-04-02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 12,661,276 | 4,880,389 ( 38.55 %) | 0 | 38.55 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
VALEO PHARMA INC. 25.72% | 25,372,987 | 25.72% | 1,649,244 $ |
CHITOGENX INC. 10.34% | 5,275,392 | 10.34% | 242,668 $ |
Company contact information
Manitex Capital, Inc.
16667 Hymus Boulevard
H9H 4R9, Kirkland
+
Sector
1st Jan change | Capi. | |
---|---|---|
+8.70% | 2.32M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- MNX Stock
- Company Manitex Capital Inc.